Todd C Davis, a director of Ligand Pharmaceuticals Incorporated, recently acquired 1,000 shares of the company. The buys took place at $93.59 per share, on August 02, 2019. Davis now owns 49,474 shares of the company. Davis operates out of San Diego, CA.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!
Other recent filings from the company include the following: